Blockchain Registration Transaction Record

Creative Diagnostics Expands Liver Metabolism Tools for Safer Drug Development

Creative Diagnostics expands hepatic metabolism products for drug research. New liver fractions help predict drug safety & effectiveness before human trials. Essential tools for pharmaceutical development.

This development directly impacts pharmaceutical safety and effectiveness by providing researchers with better tools to predict how drugs will behave in the human body. The liver processes virtually all medications, and inadequate understanding of hepatic metabolism has led to numerous drug withdrawals and adverse effects in patients. By offering standardized liver fractions from multiple species, Creative Diagnostics enables more accurate prediction of drug metabolism pathways, potential toxicities, and organ interactions before human trials. This advancement could accelerate development of safer medications while reducing costly clinical failures, ultimately benefiting patients through more predictable drug responses and fewer unexpected side effects. The tools also support research into liver diseases and metabolic disorders, contributing to broader medical knowledge about this vital organ's functions.